AR012872A1 - Uso del mometanosulfonato del acido (e)-alfa-[2-n-butil-1-[(carboxifenil)metil]-1-h-imidazol-5- il]metilen-2-tiofenpropionico para la fabricacion de un medicamento ycomposicion farmaceutica que lo comprende para tratar hipertension sistolica aislada. - Google Patents
Uso del mometanosulfonato del acido (e)-alfa-[2-n-butil-1-[(carboxifenil)metil]-1-h-imidazol-5- il]metilen-2-tiofenpropionico para la fabricacion de un medicamento ycomposicion farmaceutica que lo comprende para tratar hipertension sistolica aislada.Info
- Publication number
- AR012872A1 AR012872A1 ARP980102464A ARP980102464A AR012872A1 AR 012872 A1 AR012872 A1 AR 012872A1 AR P980102464 A ARP980102464 A AR P980102464A AR P980102464 A ARP980102464 A AR P980102464A AR 012872 A1 AR012872 A1 AR 012872A1
- Authority
- AR
- Argentina
- Prior art keywords
- methylene
- alpha
- butyl
- methyl
- acid
- Prior art date
Links
- 206010042957 Systolic hypertension Diseases 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
- -1 4-carboxyphenyl Chemical group 0.000 abstract 2
- 239000002080 C09CA02 - Eprosartan Substances 0.000 abstract 2
- OROAFUQRIXKEMV-LDADJPATSA-N eprosartan Chemical compound C=1C=C(C(O)=O)C=CC=1CN1C(CCCC)=NC=C1\C=C(C(O)=O)/CC1=CC=CS1 OROAFUQRIXKEMV-LDADJPATSA-N 0.000 abstract 2
- 229960004563 eprosartan Drugs 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La utilizacion de ácido (E)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1-H- imidazol-5-il]metilen-2-tiofenpropionico (eprosartán) en la fabricacion de unmedicamento que se destina para el tratamiento de hipertension sistolica aislada.Una composicion farmacéutica para utilizacion en el tratamiento dehipertension sistolica aislada que comprende ácido (E)-alfa-[2-n-butil-1-[(4- carboxifenil)metil]-1-H-imidazol-5-il]metilen-2-tiofdenpropionico (eprosartán yun vehículo farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4780097P | 1997-05-27 | 1997-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012872A1 true AR012872A1 (es) | 2000-11-22 |
Family
ID=21951046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102464A AR012872A1 (es) | 1997-05-27 | 1998-05-27 | Uso del mometanosulfonato del acido (e)-alfa-[2-n-butil-1-[(carboxifenil)metil]-1-h-imidazol-5- il]metilen-2-tiofenpropionico para la fabricacion de un medicamento ycomposicion farmaceutica que lo comprende para tratar hipertension sistolica aislada. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20020040045A1 (es) |
| EP (1) | EP1003506B1 (es) |
| JP (1) | JP2002500673A (es) |
| KR (1) | KR20010013014A (es) |
| CN (1) | CN1257427A (es) |
| AR (1) | AR012872A1 (es) |
| AT (1) | ATE307580T1 (es) |
| AU (1) | AU740646B2 (es) |
| BR (1) | BR9809611A (es) |
| CA (1) | CA2288722C (es) |
| CZ (1) | CZ298390B6 (es) |
| DE (1) | DE69832075T2 (es) |
| ES (1) | ES2251083T3 (es) |
| HU (1) | HUP0003249A3 (es) |
| IL (1) | IL132154A (es) |
| MX (1) | MXPA99010970A (es) |
| NO (1) | NO326141B1 (es) |
| NZ (1) | NZ337888A (es) |
| PL (1) | PL191971B1 (es) |
| SA (1) | SA98190174B1 (es) |
| TR (1) | TR199902914T2 (es) |
| TW (1) | TW579296B (es) |
| WO (1) | WO1998053816A1 (es) |
| ZA (1) | ZA984421B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060160871A1 (en) * | 2004-12-07 | 2006-07-20 | Nektar Therapeutics | Stable non-crystalline formulation comprising losartan |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US544080A (en) * | 1895-08-06 | Centrifugal filtering-machine | ||
| US5418250A (en) * | 1989-06-14 | 1995-05-23 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| JPH05199342A (ja) * | 1991-05-20 | 1993-08-06 | Xerox Corp | 無声の手書きによる携帯式通信装置および方法 |
-
1998
- 1998-05-25 ZA ZA984421A patent/ZA984421B/xx unknown
- 1998-05-27 CA CA002288722A patent/CA2288722C/en not_active Expired - Fee Related
- 1998-05-27 KR KR1019997010988A patent/KR20010013014A/ko not_active Ceased
- 1998-05-27 WO PCT/US1998/010794 patent/WO1998053816A1/en not_active Ceased
- 1998-05-27 AU AU76017/98A patent/AU740646B2/en not_active Ceased
- 1998-05-27 ES ES98923815T patent/ES2251083T3/es not_active Expired - Lifetime
- 1998-05-27 TR TR1999/02914T patent/TR199902914T2/xx unknown
- 1998-05-27 HU HU0003249A patent/HUP0003249A3/hu unknown
- 1998-05-27 PL PL336886A patent/PL191971B1/pl not_active IP Right Cessation
- 1998-05-27 IL IL13215498A patent/IL132154A/en not_active IP Right Cessation
- 1998-05-27 BR BR9809611-7A patent/BR9809611A/pt not_active Application Discontinuation
- 1998-05-27 TW TW087108204A patent/TW579296B/zh not_active IP Right Cessation
- 1998-05-27 NZ NZ337888A patent/NZ337888A/en unknown
- 1998-05-27 AR ARP980102464A patent/AR012872A1/es not_active Application Discontinuation
- 1998-05-27 MX MXPA99010970A patent/MXPA99010970A/es not_active IP Right Cessation
- 1998-05-27 EP EP98923815A patent/EP1003506B1/en not_active Expired - Lifetime
- 1998-05-27 DE DE69832075T patent/DE69832075T2/de not_active Expired - Lifetime
- 1998-05-27 CN CN98805305A patent/CN1257427A/zh active Pending
- 1998-05-27 JP JP50086599A patent/JP2002500673A/ja active Pending
- 1998-05-27 CZ CZ0420099A patent/CZ298390B6/cs not_active IP Right Cessation
- 1998-05-27 AT AT98923815T patent/ATE307580T1/de not_active IP Right Cessation
- 1998-06-17 SA SA98190174A patent/SA98190174B1/ar unknown
-
1999
- 1999-11-26 NO NO19995797A patent/NO326141B1/no not_active IP Right Cessation
-
2001
- 2001-10-24 US US09/999,808 patent/US20020040045A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO995797L (no) | 1999-11-26 |
| ES2251083T3 (es) | 2006-04-16 |
| NZ337888A (en) | 2001-04-27 |
| WO1998053816A1 (en) | 1998-12-03 |
| MXPA99010970A (es) | 2005-07-25 |
| CN1257427A (zh) | 2000-06-21 |
| TR199902914T2 (xx) | 2000-06-21 |
| NO995797D0 (no) | 1999-11-26 |
| NO326141B1 (no) | 2008-10-06 |
| BR9809611A (pt) | 2000-07-04 |
| HUP0003249A3 (en) | 2002-02-28 |
| KR20010013014A (ko) | 2001-02-26 |
| TW579296B (en) | 2004-03-11 |
| AU740646B2 (en) | 2001-11-08 |
| PL191971B1 (pl) | 2006-07-31 |
| CA2288722C (en) | 2007-04-24 |
| AU7601798A (en) | 1998-12-30 |
| EP1003506A1 (en) | 2000-05-31 |
| SA98190174B1 (ar) | 2006-05-13 |
| EP1003506A4 (en) | 2000-11-29 |
| IL132154A (en) | 2002-12-01 |
| ATE307580T1 (de) | 2005-11-15 |
| CA2288722A1 (en) | 1998-12-03 |
| CZ298390B6 (cs) | 2007-09-19 |
| JP2002500673A (ja) | 2002-01-08 |
| EP1003506B1 (en) | 2005-10-26 |
| CZ420099A3 (cs) | 2000-09-13 |
| IL132154A0 (en) | 2001-03-19 |
| DE69832075D1 (de) | 2005-12-01 |
| HUP0003249A2 (hu) | 2002-01-28 |
| DE69832075T2 (de) | 2006-07-13 |
| ZA984421B (en) | 1998-11-27 |
| US20020040045A1 (en) | 2002-04-04 |
| PL336886A1 (en) | 2000-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0000299A1 (hu) | Késleltetett hatóanyag-leadású gyógyszerkészítmények | |
| BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
| AR002030A1 (es) | Composiciones farmaceuticas para administracion a la piel o a las mucosas, y uso de una combinacion de aciclovir e hidrocortisona para la elaboracion de medicamentos | |
| AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
| AR012614A1 (es) | Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento | |
| AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
| DE60115029D1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
| ES2156840T1 (es) | Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis. | |
| ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
| MXPA03010991A (es) | Composicion permeable a la piel que comprende inhibidor de ciclooxigenasa-a selectivo y alcohol monohidrico. | |
| AR035500A1 (es) | Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina. | |
| UA88270C2 (ru) | Фармацевтический препарат и его применение для профилактики удара, диабета | |
| BR9712523A (pt) | Novos derivados de pirazol heterociclilmetil-substituìdos | |
| ES2126536A1 (es) | "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion. | |
| AR082579A2 (es) | Una composicion farmaceutica espontaneamente dispersable para la administracion oral, uso para la preparacion de un medicamento para el tratamiento del cancer, metodo para incrementar los niveles de biodisponibilidad o reducir su variabilidad | |
| ES2190692A1 (es) | Formulacion farmaceutica de amoxicilina y clavulanato de potasio. | |
| AR012376A1 (es) | Formulacion de gel para la aplicacion topica | |
| UA90077C2 (uk) | Антидисритмічні агенти для лікування тазового болю, що призначаються вагінально | |
| AR008886A1 (es) | Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea | |
| IT1255460B (it) | Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive | |
| CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
| BR0007452A (pt) | Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação | |
| ES2174533T3 (es) | Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas. | |
| SE9603480L (sv) | Beredningsform för svårlösliga läkemedel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |